Evidence map›Paper›PMID 40446700›Full record

Observational studyParkinsonism & related disorders2025

Diagnostic accuracy of screening tools for depression and anxiety in cervical dystonia.

Davide Martino, Mehrafarin Ramezani, Steven Bellows, Brian D Berman, Florence Ching-Fen Chang, Jeanne Feuerstein, Victor Fung, Gamze Kilic Berkmen, Irene A Malaty, Claire MacIver and 7 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Davide MartinoDepartment of Clinical Neuroscience, Cumming School of Medicine & Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada. Electronic address: davide.martino@ucalgary.ca.
Mehrafarin RamezaniDepartment of Clinical Neuroscience, Cumming School of Medicine & Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Steven BellowsParkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA.
Brian D BermanVCU Parkinson's and Movement Disorders Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Florence Ching-Fen ChangDepartment of Neurology, Westmead Hospital, Sydney, New South Wales, Australia.
Jeanne FeuersteinDepartment of Neurology, University of Colorado School of Medicine, Aurora, CO, USA; Department of Neurology, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA.
Victor FungSydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Gamze Kilic BerkmenDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Irene A MalatyDepartment of Neurology, University of Florida, Fixel Institute for Neurological Diseases, Gainesville, FL, USA.
Claire MacIverCardiff University Brain Research Imaging Centre (CUBRIC), Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, CF24 4HQ, United Kingdom.
Scott A NorrisDepartments of Neurology and Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Kathryn J PeallDivision of Psychological Medicine and Clinical Neurosciences, Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, CF24 4HQ, United Kingdom.
Joel S PerlmutterDepartments of Neurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Sarah Pirio RichardsonDepartment of Neurology, University of New Mexico Health Sciences Center and New Mexico VA Health Care System, Albuquerque, NM, USA.
Laura J WrightDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Zahra GoodarziDivision of Geriatric Medicine, Department of Medicine, Community Health Sciences and Clinical Neurosciences, Cumming School of Medicine, Hotchkiss Brain Institute and O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada.
Hyder A JinnahDepartment of Neurology, Human Genetics, and Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Funding

Dystonia Coalition- Pilot ProjectU54NS116025 · NINDS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2019 to 2023
$7.1M
Dystonia CoalitionU54NS065701 · NINDS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2009 to 2014
$7.0M
The Role of Striatal Cholinergic Interneurons in DystoniaR01NS124789 · NINDS · WASHINGTON UNIVERSITY · PI Scott Allen Norris · 2022 to 2026
$3.0M
Dystonia CoalitionU54TR001456 · NCATS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2015 to 2016
$2.5M
NCATS NIH HHS U54 TR001456NINDS NIH HHS R01 NS124789NINDS NIH HHS U54 NS065701NINDS NIH HHS U54 NS116025
6 · The paper itself

Abstract

introductionDespite their high prevalence and impact, depression and anxiety are not routinely screened for, and accuracy of screening procedures is unknown in adult-onset dystonia. We evaluated accuracy parameters of selected self-rated scales for depression and anxiety in patients with idiopathic cervical dystonia (CD).

methodsTwo-hundred-and-ten patients with idiopathic CD were recruited from 10 movement disorders centers from the US, Canada, Australia, and UK. At the end of each botulinum toxin cycle, participants were administered the Adult Standard Mini-International Neuropsychiatric Interview (MINI) as reference standard for depression and anxiety. Participants completed 8 self-administered index instruments (2 for depression, 2 for anxiety, and 4 combining screening for both). Sensitivity, specificity, positive and negative predictive values, covariate-adjusted area under the receiver operating characteristic curve (AUC), and likelihood ratios were calculated for all instruments.

resultsOn the MINI, 8.6 % (100 % female) fulfilled criteria for current major depressive disorder and 10.5 % (91 % female) fulfilled criteria for any current disorder amongst panic, social anxiety or generalized anxiety disorders. For depression screening, all tools had an AUC higher than 0.80, with the two most accurate being the BDI-II (AUC 0.91, sensitivity 87.5 %) and the HADS-Depression (AUC 0.88, sensitivity 93.7 %). For anxiety screening, the only instrument showing clinical usefulness was the HADS-Anxiety (AUC 0.82, sensitivity 86.3 %).

conclusionCurrent major depression can be screened in CD with high degree of accuracy using different self-administered scales, whereas existing screening tools for anxiety perform worse. Dystonia-specific instruments are less accurate than scales developed for the general population.

Indexed as

AnxietyAnxiety DisordersDepressionPsychiatric Status Rating ScalesTorticollisAdultAgedFemaleHumansMaleMiddle AgedSensitivity and SpecificityAccuracyAnxietyCervical dystoniaDepressionRating scalesScreening

Identifiers

PMID40446700
PMCPMC12573120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.